DFDe-Yun Feng

De-Yun Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


De-Yun Feng has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MicroRNA-224 Promotes Cell Migration and Invasion by Targeting HOXA5 Expression in Hepatocellular Carcinoma

    by Yuwu Liu, Chen Lin, Dongmei Wang, Sailan Wen, Junpu Wang, Zhihong Chen, Jing Du, Chao Ning, Deyun Feng

    Background MicroRNAs(miRNAs) are involved in the regulation of multiple cellular pathways and play a key role in the development and progression of tumor. Multiple studies have shown that abnormal expression of miRNAs has close relation with the incidence of HCC, but the mechanism of miRNAs in HCC still needs further research. Here, we investigated the mechanism of miR-224 in the invasion and metastasis of liver cancer. Methods We employed real-time quantitative PCR to detect the expression of miR-224 and ADAM17 and HOXA5 in HCC tissues. The expression level of HOXA5 in liver cancer tissues was further verified by immunohistochemistry (IHC). Real time PCR and Western bloting were used to detect the expression changes of ADAM17 and HOXA5 caused by overexpression or silencing of miR-224.Dual luciferase reporter assays demonstrated a direct association between miR-224 and its target gene ADAM17 and HOXA5. The migration and invasion experiment, MTT assay and flow cytometry were performed to investigate the changes of the biology function of HCC cell after overexpression or silencing of miR-224. Results The data showed that miR-224 and ADAM17 were significantly up-regulated and HOXA5 was significantly down-regulated in HCC tissues. The targeted regulatory relationship between miR-224 and its target genes ADAM17 and HOXA5 was also demonstrated. More importantly, we found that miR-224 positively regulates cell migration and invasion in HCC, miR-224 overexpression can promote the migration and invasion of BEL-7402 cell, and miR-224 silencing can suppress the migration and invasion of BEL-7402 cell. MiR-224 overexpression can result in the redistribution of cell cycle, the cell percentage of S phase was increased significantly, the cell percentage of G1 phase was decreased significantly, and there is no noticeable change for the cell percentage of G2 phase. Conclusions These results demonstrated that miR-224 may be exert the function of oncogenes in a particular link of cancer cell growth, it will become a promising biological target in the treatment strategy of hepatocellular carcinoma (HCC).

  • Open Access

    Loss of plexin-B3 in hepatocellular carcinoma

    by Yuwu Liu, Chang Wu, Ying Wang, Sailan Wen, Junpu Wang, Zhihong Chen, Qiongqiong He, Deyun Feng

    Plexins are the primary receptors of semaphorins, and participate in the majority of intracellular pathways triggered by semaphorins, including the regulation of cell adhesion and the motility of numerous cell types. Recently, several studies have reported that plexins can significantly affect different aspects of cancer cell biology, and the aberrant expression of plexins has been observed in a wide variety of tumor types. However, the expression and role of plexin‑B3 in hepatocellular carcinoma (HCC) is yet to be investigated. In the present study, plexin‑B3 expression was measured in 14 paired HCC samples and the corresponding adjacent non‑cancerous tissue by quantitative polymerase chain reaction and western blot analysis. The results indicated that the mRNA and protein expression levels of plexin‑B3 were downregulated in HCC samples when compared with the corresponding adjacent non‑cancerous tissue. In order to elucidate the correlation between clinicopathological data and the expression of plexin‑B3 in patients with HCC, 84 HCC archived specimens were analyzed by immunohistochemistry (IHC). The IHC results revealed that the protein expression level of plexin‑B3 was lower in the HCC samples compared with the corresponding adjacent non‑cancerous tissue, and plexin‑B3 underexpression was correlated with the patient gender and tumor size. In conclusion, these results indicated that loss of plexin‑B3 in HCC may be of predictive value for the occurrence and progression of HCC. Thus, plexin‑B3 may be a promising biomarker for the diagnosis and treatment of tumors in the future.


  • Open Access

    MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma

    by Yuwu Liu, Chang Wu, Ying Wang, Sailan Wen, Junpu Wang, Zhihong Chen, Qiongqiong He, Deyun Feng

    MicroRNAs (miRNAs) are key regulators in cell processes. Emerging evidence has suggested that there is a direct association between miRNAs and cancer. However, the exact regulatory mechanisms of miRNAs in tumorigenesis are poorly understood. In the present study, we showed that miR-145 is able to significantly reduce mRNA and protein expression levels of A disintegrin and metalloproteinase 17 (ADAM17) in liver cancer cells (SMMC-7721, BEL-7402 and Huh-7). Dual luciferase reporter assays confirmed that ADAM17 is a direct target of miR-145. Notably, we found that miR-145 inhibits cell proliferation and growth activity in SMMC-7721 cells. These results demonstrated that it may be exert the function of tumor suppression in a particular link of cancer cell growth. Further studies revealed that the silencing of ADAM17 decreased the proliferation and growth activity of SMMC-7721 cells. Moreover, it reduced the expression of MMP-9. In conclusion, miR-145 inhibits liver cancer cell proliferation by directly targeting ADAM17. Thus, it may become a promising biological target in the treatment strategy of hepatocellular carcinoma.


  • Open Access

    Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma

    by Yuwu Liu, Chang Wu, Ying Wang, Sailan Wen, Junpu Wang, Zhihong Chen, Qiongqiong He, Deyun Feng

    MicroRNAs (miRNAs) have been demonstrated to involve in multiple biological processes, including apoptosis, proliferation, differentiation, and metastasis [1–3]. In addition, several groups have reported that abnormalities of specific miRNAs are implicated in cancer pathogenesis [4,5]. The roles of miR-224 and miR-145 in tumorigenesis have attracted the attention of many researchers. The protein A disintegrin and metalloproteinase 17 (ADAM17) is over-expressed in many types of cancers, including hepatocellular carcinoma (HCC). ADAM17 expression is regulated by multiple miRNAs, which have been identified in several types of cancers [6,7]. In silico analysis suggested that ADAM17 is a common target of both miR-224 and miR-145. In the present study, we investigated the expression and distribution of miR-224, miR-145, and ADAM17 in HCC samples and analyzed the relationship between both miRNAs and ADAM17.


  • The effects of hepatitis C virus non-structural protein 3 on cell growth mediated by extracellular signal-related kinase cascades in human hepatocytes in vitro

    by Feng, Bo Li, Xiang Li, Yingxin Li, Hui Guo, Shu-Yan Sun, Qiong-Qiong He, Ying Wang, Junming Luo, Ji-Fang Wen, et al.

    Hepatitis C virus (HCV) infection has become a severe health problem worldwide. The viral proteins are believed to be among the most important factors that contribute to HCV mediated pathogenesis. Accumulated evidence demonstrating that HCV non-structural protein 3 (NS3) possesses oncogenic potential, and is involved in the regulation of cell proliferation has been documented. In this study, we emphasized the effect of HCV NS3 protein on cell proliferation in the immortally normal hepatocyte QSG7701 cells. The cell line transfected with plasmid expressing NS3 protein showed enhanced cell growth, extracellular signal-related kinase (ERK) activation, DNA binding activities of transcription factors of activator protein 1 (AP-1) and NF-κB, and cyclin D1 overexpression, but without activation of Jun amino-terminal kinase or p38. Pre-treatment of NS3 protein expressing cells with ERK inhibitor, PD98059, blocked the activation of AP-1 and NF-κB, and inhibited cyclin D1 expression and cell proliferation. The results suggest that NS3-mediated cell growth occurs through activation of ERK/AP-1 and NF-κB/cyclin D1 cascades.


    • 1 July 2007
      • Vol. 15  (7) , 540-1

    [Effects of HCV NS3 protein on apoptosis of QSG7701 cells induced by serum starvation].

    by Shu-Yan Sun, Hui Guo, Bo Li, Qiong-Qiong He, De-Yun Feng

    • 1 June 2007
      • Vol. 32  (3) , 387-95

    [Mechanism of hepatocyte transformation by HCV NS3 using two-dimensional electrophoresis and mass spectrometry].

    by Qiong-Qiong He, Zhu-Chu Chen, Xu-Xian Xiao, De-Yun Feng, Zhi-Qiang Xiao, Cui Li, Bo Li, Peng-Fei Zhang, Rui-Xue Cheng

    To investigate the proteome of hepatocyte transformation by hepatitis C virus (HCV) nonstructural protein 3 (NS3). Human hepatocyte line QSG7701 stably expressing HCV NS3 C-terminal deleted protein was constructed, which was named pRcHCNS3/QSG. Two-dimensional electrophoresis (2-DE) was used to separate the total protein of pRcHCNS3/QSG and pRcCMV transfected cells (pRcCMV/QSG) respectively. Differentially expressed protein spots were identified by mass spectrometry. Western blot confirmed the differentially expressed proteins. 2-DE profiles with high resolution and reproducibility were obtained. The average spots of pRcHCNS3/QSG and pRcCMV/QSG were (1183+/-77) and (1095+/-82) respectively, and (920+/-60) spots were matched. Twenty-one differentially expressed protein spots were chosen randomly and 15 were identified by mass spectrometry. Some proteins such as Ras, P38 and HD53 which were involved in signal transduction were increased in pRcHCNS3/QSG cells. Western blot also showed strong expression of phosphorylated P44/42 and P38 in pRcHCNS3/QSG cells. Other differentially expressed proteins were related to cell cycle regulation, immunoreaction, tumor invasion and metastasis, and liver metabolizability. HCV NS3 might be involved in cell malignant transformation through affecting protein expression and signal transduction such as MAPK cascade. Further study on the signal transductions and their relationship would not only be helpful to explore the mechanism of HCV related HCC, but also provide a new idea for the molecular treatment of HCC.

    • 1 April 2007
      • Vol. 32  (2) , 259-63

    [Cross-talk between ERK and NF-kappaB signal transduction pathways in the hepatocytes expressing hepatitis C virus nonstructural protein 3].

    by Hui Guo, De-Yun Feng, Bo Li, Qiong-Qiong He, Shu-Yan Sun, Rui-Xue Cheng

    To explore the cross-talk between extracellular signal-regulated kinase (ERK) and nuclear factor (NF-kappaB) signal transduction pathways in the hepatocytes expressing hepatitis C virus nonstructural protein 3 (HCV NS3). A cell line QSG7701/NS3, which stably expressed HCV NS3 protein, was constructed by transfecting plasmid pcDNA3.1-NS3 into a human immortalized hepatocyte line QSG7701. Before and after QSG7701/NS3 cells were treated by MEK inhibitor PD98059, the phosphorylation level of ERK and the expression of cyclin D1 protein were detected by Western blot; the DNA binding activities of activator protein 1 (AP-1) and NF-kappaB were evaluated with electrophoretic mobility shift assay (EMSA). Cell cycles were measured by flow cytometry (FCM); the effects of PD98059 on the cell proliferation were determined by MTT assay. HCV NS3 protein could up-regulate the phosphorylation of ERK and the expression level of cyclin D1 in QSG7701 cells. PD98059 could inhibit the cell proliferation mediated by HCV NS3 protein, down-regulate the activities of AP-1 and NF-kappaB, and suppress the expression of cyclin D1. The inhibition of ERK can suppress the DNA binding activity of NF-kappaB and the cell proliferation mediated by HCV NS3 protein in a dose-dependent manner. There may be a cross-talk between ERK and NF-kappaB signal transduction pathways, which may exert synergistic action on the proliferation and malignant transformation of hepatocytes.